EMEA MEDICINE NEWS IN BRIEFS
April 1st, 2007
BY KEITH NUTHALLTHE EUROPEAN Medicines Agency (EMEA) and the USA Food and Drug Administration (FDA) have released joint principles on how they will process and use pharmacogenetic data acquired outside standard medicine approval procedures - http://www.emea.eu.int/pdfs/human/pharmacogenetics/Guideline_on_Joint_VGDS_briefingmeetings.pdf.EMEA has also issued new standard product guidelines for human plasma fibrinogen products -http://www.emea.eu.int/pdfs/human/bpwg/12200705en.pdf.And it has issued a new paper suggesting a guideline for developing cystic fibrosis ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.